Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course (2019) Wefers AK, Stichel D, Schrimpf D, Coras R, Pages M, Tauziède-Espariat A, Varlet P, et al. Journal article Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1 (2019) Sievers P, Appay R, Schrimpf D, Stichel D, Reuss DE, Wefers AK, Reinhardt A, et al. Journal article Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimens (2017) Rapp C, Warta R, Stamova S, Nowrouzi A, Geisenberger C, Gal Z, Roesch S, et al. Journal article Myelin Regulatory Factor 1 Drives Remyelination in Multiple Sclerosis. (2017) Duncan GJ, Plemel JR, Assinck P, Manesh SB, Muir FGW, Hirata R, Berson M, et al. Journal article, Original article The toxic effect of R350P mutant desmin in striated muscle of man and mouse. (2015) Clemen C, Stöckigt F, Strucksberg KH, Chevessier F, Winter L, Schütz J, Bauer R, et al. Journal article, Original article Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYC lowBCL2low subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas (2013) Brunn A, Nagel I, Montesinos-Rongen M, Klapper W, Vater I, Paulus W, Hans V, et al. Journal article Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response (2012) Kuerten S, Schickel A, Kerkloh C, Recks MS, Addicks K, Ruddle NH, Lehmann PV Journal article